DaVita
Price: 198.54Company and Business Model
DaVita Inc. operates in the healthcare sector, primarily providing kidney care and dialysis services. The company offers a range of services including in-center hemodialysis, home dialysis, and related laboratory services. Its major business segments include dialysis services and ancillary services, with the majority of revenue generated from patient services in its dialysis centers. DaVita serves a diverse patient population across the United States and has a growing presence in international markets.
Investment Profile
The investment profile of DaVita is more aligned with growth investors, given its focus on expanding services and improving patient care. The company has shown potential for revenue growth despite recent fluctuations. It may appeal to investors looking for a balanced approach, considering its operational stability and market position.
Fundamental metrics (experimental)
- EPS (TTM) — earnings per share for the last 12 months, $
- 10.15 OK
- Revenue QoQ — quarter-over-quarter revenue growth
- -5.6% ↓
- EPS surprise
- 23.2% better than expected
- 20d volatility
- 1.9% stable
Track in portfolio
Price chart
| Date | Before | After | Reason |
|---|---|---|---|
| 2026-06-10 00:47 | Hold | Buy | Strong momentum and positive EPS surprise support growth outlook. |
| 2026-06-01 02:36 | Buy | Hold | Strong momentum but recent revenue decline raises concerns. |
| 2026-05-16 02:40 | Hold | Buy | Strong momentum and positive EPS surprise support bullish outlook. |
| Date | Analyst | Action | Target | Price Then |
|---|---|---|---|---|
| 2026-05-08 11:56 | Truist Financial | Target Raised | 158 → 205 | 194.385 |
| 2026-05-07 09:46 | Barclays | Target Raised | 158 → 194 | 193.88 |
| 2026-05-06 08:37 | Deutsche Bank | Rating Upgraded | — → 220 | 157.04 |